Cargando…

Comment on: “Fibroblast growth factor 21 controls mitophagy and muscle mass” by Oost et al.

Detalles Bibliográficos
Autores principales:	Wu, Yeshun, Zhu, Bin, Chen, Zijun, Duan, Jiahao, Yang, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015229/ https://www.ncbi.nlm.nih.gov/pubmed/31307122 http://dx.doi.org/10.1002/jcsm.12465

Ejemplares similares

The authors reply: Letter on: “Fibroblast growth factor 21 controls mitophagy and muscle mass” by Oost et al.
por: Oost, Lynette J., et al.
Publicado: (2019)

Fibroblast growth factor 21 controls mitophagy and muscle mass
por: Oost, Lynette J., et al.
Publicado: (2019)

Comment on: “Pitfalls in the measurement of muscle mass: a need for a reference standard” by Buckinx et al.
por: Clark, Brian C., et al.
Publicado: (2019)

Response to comment by Moxon et al.
por: Thompson, Dawn, et al.
Publicado: (2018)

Response to comment by Guerra et al.
por: Yang, Xinyue, et al.
Publicado: (2018)

Response to comment from Brasky et al.
por: Verdoodt, F., et al.
Publicado: (2016)

Authors’ reply to the comment from Uchida et al.
por: Osawa, Itsuki, et al.
Publicado: (2023)

Authors’ reply to the comment from Glass et al.
por: Kotani, Yuki, et al.
Publicado: (2023)

Serum Levels of FGF21, β-Klotho, and BDNF in Stable Coronary Artery Disease Patients With Depressive Symptoms: A Cross-Sectional Single-Center Study
por: Wu, Yeshun, et al.
Publicado: (2021)

Comment on the exchange between Boddy et al. and Wagner et al.: malignancy, placentation and litter size
por: Haig, David
Publicado: (2020)

Authors’ reply to the comment from Benavides-Zora et al.
por: Kotani, Yuki, et al.
Publicado: (2023)

Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.
por: Chen, Guang, et al.
Publicado: (2022)

Reply by Pan et al. to Haouzi et al.
por: Pan, Chun, et al.
Publicado: (2020)

On the History of dermatology: the study of skin diseases over the centuries - Response to the observations and comments by Mirzaei MR et al. and Rashmi TM et al()()
por: Ferreira, Iago Gonçalves, et al.
Publicado: (2021)

Comment on: “Tumour-agnostic drugs in paediatric cancers”, Chisholm et al., BJC 2020
por: Oliver, Thomas Richard William, et al.
Publicado: (2020)

The Authors reply: “Dual energy X‐ray absorptiometry: gold standard for muscle mass?” by Scafoglieri et al.
por: Buckinx, Fanny, et al.
Publicado: (2018)

Metabolic remodeling induced by mitokines in heart failure
por: Duan, Jiahao, et al.
Publicado: (2019)

Cryobiopsy Compared with Surgical Lung Biopsy in ILD: Reply to Maldonado et al., Froidure et al., Bendstrup et al., Agarwal et al., Richeldi et al., Rajchgot et al., and Quadrelli et al.
por: Romagnoli, Micaela, et al.
Publicado: (2019)

Comment on Parker et al. (Evolution, Medicine and Public Health 2021;9:120–30.)
por: Rook, Graham A.W.
Publicado: (2021)

The authors reply: Letter on: “Pitfalls in the measurement of muscle mass: a need for a reference standard” by Clark et al.
por: Buckinx, Fanny, et al.
Publicado: (2019)

Reply by Gattinoni et al. to Hedenstierna et al., to Maley et al., to Fowler et al., to Bhatia and Mohammed, to Bos, to Koumbourlis and Motoyama, and to Haouzi et al.
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Comment on Tauriainen et al.: Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD
por: Plat, Jogchum, et al.
Publicado: (2018)

Reply to Cottin et al., to Johannson et al., to Scholand and Wells, and to Crowley et al.
por: Raghu, Ganesh, et al.
Publicado: (2022)

Reply to Li et al.
por: Chen, Dongyu, et al.
Publicado: (2022)

Reply to Lescoat et al. and to Khamis et al.
por: Adegunsoye, Ayodeji, et al.
Publicado: (2019)

Reply to Chase et al. and to Milner et al.
por: Mittel, Aaron M., et al.
Publicado: (2020)

Reply by Xu et al. to Haouzi et al.
por: Xu, Yonghao, et al.
Publicado: (2020)

Reply to Topeli et al. and to Akinosoglou et al.
por: Azevedo, Luciano C. P., et al.
Publicado: (2020)

Reply to Turnbull et al. and to Hulme et al.
por: Breuer, Oded, et al.
Publicado: (2020)

Reply to Shoemark et al. and to Shapiro et al.
por: Amirav, Israel, et al.
Publicado: (2020)

Reply to Gueret et al. and to Hammond et al.
por: Brown, Ryan M., et al.
Publicado: (2020)

Reply to Blot et al. and to Inoue et al.
por: McElvaney, Oliver J., et al.
Publicado: (2021)

Reply to Sanfilippo et al. and to Caviedes et al.
por: Arachchillage, Deepa J., et al.
Publicado: (2021)

Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021)

Reply to Nie et al. and Bhammar et al.
por: Peters, Michael C., et al.
Publicado: (2022)

Reply to Fillatre et al. and Li et al.
por: Abdul-Aziz, Mohd H., et al.
Publicado: (2022)

Prevalence and predisposing factors of depressive symptoms in patients with stable coronary artery disease: a cross-sectional single-center study
por: Wu, Yeshun, et al.
Publicado: (2019)

Comments on Boddy et al. 2020: Available data suggest positive relationship between placental invasion and malignancy
por: Wagner, Günter P, et al.
Publicado: (2020)

Correspondence on Lovell et al.: response to Bornelöv et al.
por: Lovell, Peter V., et al.
Publicado: (2017)

Reply to T. Hasegawa et al and I. Gross et al
por: Leyland-Jones, Brian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d94592mjea19dutdgdpdfoofrg